It can be associated with the regulation of the Hypothalamus, it affects the biological clock or circadian clock
Based on the mechanism and available evidence, most experts expect acceptable long-term safety, but this remains an area where caution is warranted
What this adds up to clinically: GLP-1s are best understood as treating the underlying metabolic disease, not just as a weight loss intervention
If you are participating in a clinical trial involving retatrutide and notice changes in your mental health, it is important not to dismiss these as unrelated to your treatment
Semaglutide, liraglutide, and dulaglutide have demonstrated cardiovascular benefits in clinical trials, with Wegovy (semaglutide 2.4 mg) recently receiving FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and obesity
Athletes focus on the compound for its ability to heal underlying damage rather than building raw volume